Literature DB >> 18620745

Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness.

Kiyoshi Hirahara1, Masakatsu Yamashita, Chiaki Iwamura, Kenta Shinoda, Akihiro Hasegawa, Hirohisa Yoshizawa, Haruhiko Koseki, Fumitake Gejyo, Toshinori Nakayama.   

Abstract

BACKGROUND: Studies of human asthma and of animal models of allergic inflammation/asthma highlight a crucial role for T(H)2 cells in the pathogenesis of allergic asthma. Repressor of GATA (ROG) is a POZ (BTB) domain-containing Kruppel-type zinc finger family (or POK family) repressor. A repressive function to GATA3, a master transcription factor for T(H)2 cell differentiation, is indicated.
OBJECTIVE: The aim of this study was to clarify the regulatory roles of ROG in the pathogenesis of T(H)2-driven allergic diseases, such as allergic asthma.
METHODS: We examined allergic airway inflammation and airway hyperresponsiveness (AHR) in 3 different mouse models, which use either ROG-deficient (ROG(-/-)) mice, ROG transgenic mice, or adoptive transfer of cells.
RESULTS: In ROG(-/-) mice T(H)2 cell differentiation, T(H)2 responses, eosinophilic airway inflammation, and AHR were enhanced. In ROG transgenic mice the levels of eosinophilic airway inflammation and AHR were dramatically reduced. Furthermore, adoptive transfer of T(H)2 cells with increased or decreased levels of ROG expression into the asthmatic mice resulted in reduced or enhanced airway inflammation, respectively.
CONCLUSION: These results indicate that ROG regulates allergic airway inflammation and AHR in a negative manner, and thus ROG might represent another potential therapeutic target for the treatment of asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620745     DOI: 10.1016/j.jaci.2008.06.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  24 in total

Review 1.  Helper T-cell differentiation and plasticity: insights from epigenetics.

Authors:  Kiyoshi Hirahara; Golnaz Vahedi; Kamran Ghoreschi; Xiang-Ping Yang; Shingo Nakayamada; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 2.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

3.  Influence of an Exergaming Training Program on Reducing the Expression of IL-10 and TGF-β in Cancer Patients.

Authors:  Ricardo da Silva Alves; Douglas Reis Abdalla; Denise Hollanda Iunes; Karina Oliveira Prado Mariano; Juliana Bassalobre Carvalho Borges; Eddie Fernando Cândido Murta; Márcia Antoniazi Michelin; Leonardo César Carvalho
Journal:  Games Health J       Date:  2020-06-04

4.  Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation.

Authors:  Lai Wei; Golnaz Vahedi; Hong-Wei Sun; Wendy T Watford; Hiroaki Takatori; Haydee L Ramos; Hayato Takahashi; Jonathan Liang; Gustavo Gutierrez-Cruz; Chongzhi Zang; Weiqun Peng; John J O'Shea; Yuka Kanno
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

5.  A ROG(ue) in charge of the (natural) killers.

Authors:  Thomas Ciucci; Rémy Bosselut
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 6.  Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.

Authors:  Kiyoshi Hirahara; Amanda Poholek; Golnaz Vahedi; Arian Laurence; Yuka Kanno; Joshua D Milner; John J O'Shea
Journal:  J Allergy Clin Immunol       Date:  2013-05       Impact factor: 10.793

7.  DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.

Authors:  Jeffrey D Price; Chie Hotta-Iwamura; Yongge Zhao; Nicole M Beauchamp; Kristin V Tarbell
Journal:  Diabetes       Date:  2015-06-12       Impact factor: 9.461

8.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

9.  The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection.

Authors:  Aimee M Beaulieu; Carolyn L Zawislak; Toshinori Nakayama; Joseph C Sun
Journal:  Nat Immunol       Date:  2014-04-20       Impact factor: 25.606

10.  Stepwise epigenetic and phenotypic alterations poise CD8+ T cells to mediate airway hyperresponsiveness and inflammation.

Authors:  Yi Jia; Katsuyuki Takeda; Junyan Han; Anthony Joetham; Roland A Marcus; Joseph J Lucas; Brian P O'Connor; Erwin W Gelfand
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.